Go Pro
→ Elon Warns 'America Will Go Bankrupt'. Trump's Plan Inside. (From American Hartford Gold) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$6.45
-2.7%		$3.44
$1.41
▼
$41.35
$4.59M1.214.92 million shs40,818 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.84
-1.1%		$0.94
$0.80
▼
$16.68
$3.74M0.892.84 million shs113,924 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.06
-2.4%		$0.10
$0.05
▼
$0.75
$1.15M1.2151,240 shs63,136 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$0.85
+6.3%		$1.05
$0.02
▼
$1.90
$4.06M1.811,280 shs1,043 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
0.00%+2.71%+234.20%+81.66%-82.30%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%-9.19%-1.45%-26.61%-86.33%
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-18.14%-41.83%-59.01%-88.88%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%-43.33%-29.17%+41.67%+183.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$6.45
-2.7%		$3.44
$1.41
▼
$41.35
$4.59M1.214.92 million shs40,818 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$0.84
-1.1%		$0.94
$0.80
▼
$16.68
$3.74M0.892.84 million shs113,924 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.06
-2.4%		$0.10
$0.05
▼
$0.75
$1.15M1.2151,240 shs63,136 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$0.85
+6.3%		$1.05
$0.02
▼
$1.90
$4.06M1.811,280 shs1,043 shs
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
0.00%+2.71%+234.20%+81.66%-82.30%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%-9.19%-1.45%-26.61%-86.33%
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-18.14%-41.83%-59.01%-88.88%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%-43.33%-29.17%+41.67%+183.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.50
Reduce$1.50-76.74% Downside
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BTCY, AEMD, SONX, and BJDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/18/2026
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
8/18/2026
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$1.50
7/17/2026
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/A$15.56 per shareN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$8.43 per shareN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M0.10N/AN/A($1.30) per share-0.04
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.09N/AN/A$89.42 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$7.15M-$34.97N/AN/AN/AN/A-123.08%-99.28%11/11/2026 (Estimated)
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$7.11N/AN/AN/AN/A-125.00%-99.79%11/13/2026 (Estimated)
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$0.14N/AN/AN/A-80.42%N/A-188.47%11/12/2026 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$71.12N/AN/AN/A-92.74%-184.01%-68.60%11/11/2026 (Estimated)

Latest BTCY, AEMD, SONX, and BJDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q1 2027
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$3.92-$4.02-$0.10-$4.02N/AN/A
8/12/2026Q2 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.12+$3,518.88-$1.12N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
5.42
5.42
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
0.60%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
Biotricity, Inc. stock logo
BTCY
Biotricity
1.60%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
9711,000707,000No Data
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
64.47 million4.20 millionNot Optionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4620.08 million22.08 millionNo Data
Sonendo, Inc. stock logo
SONX
Sonendo
2504.78 million393,000Not Optionable

Recent News About These Companies

Sonendo Achieves Milestone of Two Million Patients Treated with the GentleWave® Procedure
September 21, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260921529965/en/sonendo-achieves-milestone-of-two-million-patients-treated-with-the-gentlewave%c2%ae-procedure/
Sonendo Announces Key Initiatives to Drive Business Towards Cashflow Break-Even
August 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260825390808/en/sonendo-announces-key-initiatives-to-drive-business-towards-cashflow-break-even/
Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024
June 26, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20241029781245/en/Sonendo-Inc.-to-Report-Third-Quarter-2024-Financial-Results-on-November-12-2024
Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga
April 8, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SONX
Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
March 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260316143036/en/sonendo-inc.-on-path-to-breakeven-in-the-second-half-of-2026/
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...
August 22, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer
Sonendo names John McGaugh COO
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/sonendo-names-john-mcgaugh-coo/ar-AA1KU4kG
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
August 20, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250820399898/en/Sonendo-Strengthens-Leadership-Team-With-Promotion-of-John-McGaugh-to-Chief-Operating-Officer/
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
August 13, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250813720540/en/sonendo-inc.-reports-second-quarter-2025-financial-results-and-reaffirms-financial-guidance/
Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
June 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250604534828/en/Sonendo-Inc.-Reports-First-Quarter-2025-Financial-Results-and-Issues-Financial-Guidance/
Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250326534061/en/sonendo-inc.-reports-fourth-quarter-and-full-year-2024-financial-results/
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
November 11, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241111083660/en/sonendo-inc.-to-release-third-quarter-2024-financial-results-and-postpone-conference-call-on-november-12-2024/
Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
November 5, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2364453/sonendo-inc-sonx-may-report-negative-earnings-know-the-trend-ahead-of-next-week-s-release?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2364453
Sonendo Launches ProControlTM for the GentleWave® G4 System
October 23, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241023284533/en/sonendo-launches-procontroltm-for-the-gentlewave%c2%ae-g4-system/
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
October 10, 2024  |  businesswire.comhttps://www.businesswire.com/news/home/20241010657314/en/sonendo-inc.-announces-preliminary-third-quarter-2024-financial-results/
BIOLASE files for Chapter 11, plans asset sale to Sonendo
October 3, 2024  |  investing.comhttps://www.investing.com/news/company-news/biolase-files-for-chapter-11-plans-asset-sale-to-sonendo-3643778
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
August 27, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2327671/here-s-why-sonendo-sonx-is-a-great-buy-the-bottom-stock-now?cid=cs-stocknewsapi-ft-tale_of_the_tape|hammer_chart_pattern_(ta)-2327671
Sonendo Inc.
August 17, 2024  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SONX/financials/secfilings
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
August 10, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4713322-sonendo-inc-sonx-q2-2024-earnings-call-transcript
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
August 7, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2318510/sonendo-inc-sonx-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2318510

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aethlon Medical stock logo

Aethlon Medical NASDAQ:AEMD

$6.45 -0.18 (-2.71%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$6.50 +0.05 (+0.78%)
As of 10/2/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$0.84 -0.01 (-1.12%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.83 -0.01 (-0.79%)
As of 10/2/2026 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.06 0.00 (-2.39%)
As of 10/2/2026 03:56 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Sonendo stock logo

Sonendo NYSE:SONX

$0.85 +0.05 (+6.25%)
As of 10/2/2026 01:37 PM Eastern

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas